Log In
Print this Print this

NPM1 assay (Signature NPM1 Mutations assay)

  Manage Alerts
Collapse Summary General Information
Company Asuragen Inc.
DescriptionRNA-based assay combining multiplex RT-PCR with fluorescent bead-based detection for determining NPM1 mutation status
Molecular Target Nucleophosmin (NPM1) (B23)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDetect NPM1 mutations in patients with acute myelogenous leukemia (AML)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today